Back to Search
MATTHEW LAWLER, M.D.
M.D.
Hospitalist Physician
NPI: 1629363767IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
258793(MA)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
258793(MA)
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 2011
Research & Publications (20)
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
PMID 19183198·Br J Haematol·2009
8-other
Impact of conversion to critical access hospital status for Oklahoma's rural hospitals.
PMID 12696849·J Rural Health·2003
8-other
Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
PMID 11919737·Bone Marrow Transplant·2002
5-case
Prospective chimerism analysis, the time is now but can we respond?
PMID 11753624·Leukemia·2001
8-other
Dual targeting of tumour cells and host endothelial cells by novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines.
PMID 19479253·Cancer Chemother Pharmacol·2010
8-other
Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia.
PMID 19495836·Ir J Med Sci·2009
8-other
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.
PMID 19106642·Cancer Biol Ther·2009
8-other
Pica as an adaptive response: Kaolin consumption helps rats recover from chemotherapy-induced illness.
PMID 19419663·Physiol Behav·2009
7-preclinical
Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide.
PMID 19478055·Blood·2009
8-other
4-Amino-1,8-naphthalimide-based Tröger's bases as high affinity DNA targeting fluorescent supramolecular scaffolds.
PMID 19681640·Org Lett·2009
8-other
Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
PMID 19051213·J Gene Med·2009
8-other
Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
PMID 19016726·Br J Haematol·2009
4-observational
The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
PMID 19014913·Biochem Pharmacol·2009
8-other
Theory of Néel and valence-bond solid phases on the kagome lattice of Zn paratacamite.
PMID 18518414·Phys Rev Lett·2008
8-other
The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate?
PMID 18615772·J Gene Med·2008
7-preclinical
Topological spin liquid on the hyperkagome lattice of Na4Ir3O8.
PMID 18643453·Phys Rev Lett·2008
8-other
Quantum order by disorder in frustrated diamond lattice antiferromagnets.
PMID 18764361·Phys Rev Lett·2008
8-other
Gapless spin liquids on the three-dimensional hyperkagome lattice of Na4Ir3O8.
PMID 19113300·Phys Rev Lett·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 WASHINGTON ST
BOSTON, MA 02111 - Phone
- (617) 636-5000
Quick Facts
- NPI
- 1629363767
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile